Group a streptococcal emm type prevalence among symptomatic children in cape town and potential vaccine coverage

Mark E. Engel, Babu Muhamed, Andrew C. Whitelaw, Munyaradzi Musvosvi, Bongani M. Mayosi, James Dale

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The molecular epidemiology of group A streptococcal pharyngeal infections in children in the Vanguard Community of Cape Town revealed 26 emm types among 157 isolates from 742 subjects. Coverage of a 30-valent vaccine is predicted to be 95% of pharyngitis cases in this population at high risk of rheumatic fever.

Original languageEnglish (US)
Pages (from-to)208-210
Number of pages3
JournalPediatric Infectious Disease Journal
Volume33
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Streptococcal Infections
Rheumatic Fever
Molecular Epidemiology
Pharyngitis
Vaccines

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Group a streptococcal emm type prevalence among symptomatic children in cape town and potential vaccine coverage. / Engel, Mark E.; Muhamed, Babu; Whitelaw, Andrew C.; Musvosvi, Munyaradzi; Mayosi, Bongani M.; Dale, James.

In: Pediatric Infectious Disease Journal, Vol. 33, No. 2, 01.01.2014, p. 208-210.

Research output: Contribution to journalArticle

Engel, Mark E. ; Muhamed, Babu ; Whitelaw, Andrew C. ; Musvosvi, Munyaradzi ; Mayosi, Bongani M. ; Dale, James. / Group a streptococcal emm type prevalence among symptomatic children in cape town and potential vaccine coverage. In: Pediatric Infectious Disease Journal. 2014 ; Vol. 33, No. 2. pp. 208-210.
@article{6fa80466d4a34b07a97b4123483eeafc,
title = "Group a streptococcal emm type prevalence among symptomatic children in cape town and potential vaccine coverage",
abstract = "The molecular epidemiology of group A streptococcal pharyngeal infections in children in the Vanguard Community of Cape Town revealed 26 emm types among 157 isolates from 742 subjects. Coverage of a 30-valent vaccine is predicted to be 95{\%} of pharyngitis cases in this population at high risk of rheumatic fever.",
author = "Engel, {Mark E.} and Babu Muhamed and Whitelaw, {Andrew C.} and Munyaradzi Musvosvi and Mayosi, {Bongani M.} and James Dale",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/INF.0b013e3182a5c32a",
language = "English (US)",
volume = "33",
pages = "208--210",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Group a streptococcal emm type prevalence among symptomatic children in cape town and potential vaccine coverage

AU - Engel, Mark E.

AU - Muhamed, Babu

AU - Whitelaw, Andrew C.

AU - Musvosvi, Munyaradzi

AU - Mayosi, Bongani M.

AU - Dale, James

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The molecular epidemiology of group A streptococcal pharyngeal infections in children in the Vanguard Community of Cape Town revealed 26 emm types among 157 isolates from 742 subjects. Coverage of a 30-valent vaccine is predicted to be 95% of pharyngitis cases in this population at high risk of rheumatic fever.

AB - The molecular epidemiology of group A streptococcal pharyngeal infections in children in the Vanguard Community of Cape Town revealed 26 emm types among 157 isolates from 742 subjects. Coverage of a 30-valent vaccine is predicted to be 95% of pharyngitis cases in this population at high risk of rheumatic fever.

UR - http://www.scopus.com/inward/record.url?scp=84893025754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893025754&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e3182a5c32a

DO - 10.1097/INF.0b013e3182a5c32a

M3 - Article

VL - 33

SP - 208

EP - 210

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 2

ER -